Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes: a meta-analysis of real-world evidence.

Salman HussainAmbrish SinghHarveen BaxiBruce TaylorJohn BurgessBenny Antony

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)

This meta-analysis demonstrates a potential neuroprotective effect of TZD for PD risk in the population with DM.

Keyphrases

systematic review
meta analyses
cerebral ischemia
randomized controlled trial
glycemic control
risk assessment
insulin resistance
weight loss